Vericel

1 stories about Vericel
מדיוונד שרון מלכה

Burn Treatment Company MediWound Enters Licensing Agreement with Vericel

10.05.19|Micky Grunfeld
The agreement, for commercial rights in North America to Mediwound’s flagship burn treatment NexoBrid, could net the company up to $150 million
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1